For instance, Miyata et al. (2021) found that the hepatic mRNA expression abundance of HMOX-1 was down-regulated (0.19 vs. 1.00) by a selenoneine supplementation in mice with non-alcoholic fatty liver disease [57]. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.